Events

WPC | Nov 27-30, 2018

We're excited to announce that Christian Schmees will present our patient-derived 3D microtumor / immune cell assay platform at WPC in Lisbon.

ENA | Nov 13-16, 2018

Michael Pawlak will take part in the 30th EORTC-NCI-AACR Symposium. He will present a poster with our latest results on RPPA protein profiling of patient-derived 3D microtumor models.

xMAP Connect | Nov 6-7, 2018

As a Luminex partner, we are sponsoring xMAP Connect in Amsterdam, organized by Luminex. Meet Thomas Joos, Markus Templin, and Nicole Schneiderhan-Marra at our booth, and get the most recent updates on DigiWest and on our modified Luminex bead products.

R2N Symposium | Nov 6-7, 2018

Udo Kraushaar is participating at the R2N Symposium in Hannover and will give the talk entitled: Transforming (stem) cell models from academic research to pharma –  about assay development and validation.

ESTIV | Oct 15-18, 2018

We offer protein profiling assays for safety and toxicology - please see Christoph Sachse's poster at the 20th International Congress on In Vitro Toxicology (ESTIV) in Berlin.

ELRIG Drug Discovery | Oct 9-10, 2018

London Calling ... Christoph Sachse and Richard Griesbach look forward to meeting you in London at ELRIG's Drug Discovery Meeting. At booth C2 we will highlight our cell-based offerings: customized cell lines, hiPSC models and immuno-oncology testing services. And don't miss Richard's talk on CRISPR cell models.

MipTec | Sep 11-14, 2018

It's MipTec time again! Christoph Sachse will be in Basel to meet our Swiss clients at Basel Life.

Goodbye Flat Biology | Sep 9-12, 2018

We're sponsoring EACR's Goodbye Flat Biology. Meet Simge Yüz and Christoph Sachse at our booth and see our posters on the use of patient-derived 3D cell models for immuno-therapy testing.

Sophion User Meeting | Sep 5-6, 2018

Our electrophysiology experts Timm Danker and Alejandra Bärfuss will be attending the Sophion European User Meeting in Stevenage, UK.

Immuno-Oncology Summit | Aug 27-31, 2018

Christoph Sachse will take part in CHI's Immuno-Oncology Summit in Boston on August 27-31, with a poster on DigiWest and with a talk on our latest results using patient-derived microtumor/immune cell co-cultures.